Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-30 @ 3:44 PM
Study NCT ID:
NCT02312557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-03
First Post:
2014-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
Sponsor:
OHSU Knight Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2014-12-04
First Submit QC Date:
None
Study First Post Date:
2014-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-09-19
Results First Submit QC Date:
None
Results First Post Date:
2025-01-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-19
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED